BioCryst Pharmaceuticals Price Target Raised to $19.00/Share From $14.00 by HC Wainwright & Co.
BioCryst Pharmaceuticals Price Target Raised to $19.00/Share From $14.00 by HC Wainwright & Co.
DJ BioCryst Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.
Ratings actions from Benzinga: https://www.benzinga.com/stock/BCRX/ratings
(END) Dow Jones Newswires
March 24, 2021 06:48 ET (10:48 GMT)
DJ BioCryst Pharmaceuticals Price Target Raised to $19.00/Share From $14.00 by HC Wainwright & Co.
Ratings actions from Benzinga: https://www.benzinga.com/stock/BCRX/ratings
(END) Dow Jones Newswires
March 24, 2021 06:48 ET (10:48 GMT)
DJ BioCryst Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.
DJ BioCryst製藥公司由HC Wainwright&Co.維持在Buy。
Ratings actions from Benzinga: https://www.benzinga.com/stock/BCRX/ratings
來自本辛加的評級行動:https://www.benzinga.com/stock/BCRX/ratings
(END) Dow Jones Newswires
(完)道瓊通訊社
March 24, 2021 06:48 ET (10:48 GMT)
2021年3月24日東部時間06:48(格林尼治標準時間10:48)
DJ BioCryst Pharmaceuticals Price Target Raised to $19.00/Share From $14.00 by HC Wainwright & Co.
DJ BioCryst製藥公司將目標價從每股14.00美元提高到19.00美元,由HC Wainwright&Co.
Ratings actions from Benzinga: https://www.benzinga.com/stock/BCRX/ratings
來自本辛加的評級行動:https://www.benzinga.com/stock/BCRX/ratings
(END) Dow Jones Newswires
(完)道瓊通訊社
March 24, 2021 06:48 ET (10:48 GMT)
2021年3月24日東部時間06:48(格林尼治標準時間10:48)
譯文內容由第三人軟體翻譯。
風險及免責聲明
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧